You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Skin infections

Adalimumab for treating moderate to severe hidradenitis suppurativa

  • Technology appraisal guidance
  • Reference number: TA392
  • Published:  22 June 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Tools and resources

Tools and resources to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top